The advent of artificial intelligence and machine learning already promises to shave months to years off of the typical drug discovery timeline—but why stop there? Entos believes it can make the process even faster while using fewer data resources, and it’s raised $53 million to help catapult its efforts.
Other articles
June 28, 2024
Freeflow Ventures Raises $90M In Funding For Early Stage Deep Tech Investments
Freeflow Ventures, announced today that it raised $50M in new funds through its…